Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9177 |
High Similarity |
NPD6959 |
Discontinued |
0.9073 |
High Similarity |
NPD7390 |
Discontinued |
0.8882 |
High Similarity |
NPD6232 |
Discontinued |
0.8834 |
High Similarity |
NPD7473 |
Discontinued |
0.8545 |
High Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8543 |
High Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.8447 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8408 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8395 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8344 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8291 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8291 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8291 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8291 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8289 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8261 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8229 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.821 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8199 |
Intermediate Similarity |
NPD3226 |
Approved |
0.8182 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8182 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8158 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8136 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8129 |
Intermediate Similarity |
NPD5406 |
Approved |
0.8129 |
Intermediate Similarity |
NPD5405 |
Approved |
0.8129 |
Intermediate Similarity |
NPD5404 |
Approved |
0.8129 |
Intermediate Similarity |
NPD5408 |
Approved |
0.811 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.807 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8065 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.8046 |
Intermediate Similarity |
NPD8313 |
Approved |
0.8046 |
Intermediate Similarity |
NPD8312 |
Approved |
0.8038 |
Intermediate Similarity |
NPD7003 |
Approved |
0.8025 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.795 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7911 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7904 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7898 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7892 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7874 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7857 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7849 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7849 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7848 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7848 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7831 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7829 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7812 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7785 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7778 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7765 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7759 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7751 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.775 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7736 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.773 |
Intermediate Similarity |
NPD6780 |
Approved |
0.773 |
Intermediate Similarity |
NPD6776 |
Approved |
0.773 |
Intermediate Similarity |
NPD6779 |
Approved |
0.773 |
Intermediate Similarity |
NPD6781 |
Approved |
0.773 |
Intermediate Similarity |
NPD6778 |
Approved |
0.773 |
Intermediate Similarity |
NPD6782 |
Approved |
0.773 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7707 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7701 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7701 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7701 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7697 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7692 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7683 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7679 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7679 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7674 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7674 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7651 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.764 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7625 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7619 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7614 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7606 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7605 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.76 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7562 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7562 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7557 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7545 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7539 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7529 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7529 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7514 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7514 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD3748 |
Approved |
0.75 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7486 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7485 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7475 |
Intermediate Similarity |
NPD7654 |
Discontinued |
0.7472 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7472 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7468 |
Intermediate Similarity |
NPD943 |
Approved |
0.7461 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7461 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7459 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7459 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7455 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7453 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7439 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7434 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7433 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7433 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.743 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7427 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7425 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7425 |
Intermediate Similarity |
NPD920 |
Approved |
0.7423 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7423 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7412 |
Intermediate Similarity |
NPD37 |
Approved |
0.7401 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7391 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7389 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7378 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7371 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7368 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7342 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7305 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7305 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7299 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7293 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7292 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7292 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7284 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7283 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7283 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7283 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7273 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7264 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7263 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7243 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7237 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7233 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7233 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7219 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.7219 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7219 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.7216 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7215 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7207 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7198 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7197 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7186 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7179 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7174 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7173 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7169 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7168 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7161 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7125 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7111 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7105 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7102 |
Intermediate Similarity |
NPD919 |
Approved |
0.7101 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7099 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7091 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7077 |
Intermediate Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7043 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7031 |
Intermediate Similarity |
NPD8285 |
Discontinued |
0.7022 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7011 |
Intermediate Similarity |
NPD8453 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.6988 |
Remote Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.6987 |
Remote Similarity |
NPD1281 |
Approved |
0.6968 |
Remote Similarity |
NPD4626 |
Approved |
0.6964 |
Remote Similarity |
NPD8166 |
Discontinued |
0.6962 |
Remote Similarity |
NPD1876 |
Approved |
0.6944 |
Remote Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.6941 |
Remote Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.6933 |
Remote Similarity |
NPD2979 |
Phase 3 |
0.6932 |
Remote Similarity |
NPD4288 |
Approved |
0.6932 |
Remote Similarity |
NPD2296 |
Approved |
0.6928 |
Remote Similarity |
NPD405 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD8059 |
Phase 3 |
0.6923 |
Remote Similarity |
NPD8058 |
Clinical (unspecified phase) |
0.6918 |
Remote Similarity |
NPD1164 |
Approved |
0.6918 |
Remote Similarity |
NPD1203 |
Approved |
0.6899 |
Remote Similarity |
NPD4749 |
Approved |
0.6894 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.6875 |
Remote Similarity |
NPD5761 |
Phase 2 |
0.6875 |
Remote Similarity |
NPD5760 |
Phase 2 |
0.6875 |
Remote Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.6872 |
Remote Similarity |
NPD6746 |
Phase 2 |
0.6869 |
Remote Similarity |
NPD6973 |
Clinical (unspecified phase) |
0.6867 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6865
|
Remote Similarity |
NPD7240 |
Approved |